Alendronate-induced esophagitis in an elderly woman

International Journal of Clinical and Experimental Pathology

Volumn 2, Issue 2, 2009, Pages 200-203

  Gómez, Victoria ^a   Xiao, Shu Yuan ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Alendronate sodium; Esophagitis; Fosamax

Indexed keywords

EID: 67149102165     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Edqueker J and Favus M. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 1995;333:1437-1443.
2. Siris E, Weinstein RS, Altman R, Conte JM, Favus M, Lombardi A, Lyles K, McIlwain H, Murphy WA Jr, Reda C, Rude R, Seto M, Tiegs R, Thompson D, Rucci JR, Yates AJ and Zimering M. Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone. J Clin Endocrine Metab 1996;81:961-967.
3. de Groen PC, Lubbe DF, Hirsch LJ, Daifotis A, Stephenson W, Freedholm D, Pryor-Tillotson S, Seleznick MJ, Pinkas H and Wang KK. Esophagitis associated with the use of alendronate. N Engl J Med 1995;335:1016-1021.
4. Nightingale SL. From the Food and Drug Administration. JAMA 1996;275:1534.
5. Graham DY. What the gastroenterologist should know about the gastrointestinal Safety profiles of bisphosphonates. Dig Dis Sci 2002; 47:1665-1678.
6. Kikendall JW. Pill esophagitis. J Clin Gastroenterol 1999;28:298-305.
7. Abraham SC, Cruz-Correa M, Lee LA, Yardley JH and Wu T-T. Alendronate-associated esophageal injury: pathologic and endoscopic features. Mod Pathol 1999;12:1152-1157.
8. Singh SP and Odze RD. Multinucleated epithelial giant cell changes in esophagitis: a clinicopathologic study of 14 cases. Am J Surg Pathol 1998;22:93-99.
9. Ribeiro A. DeVault KR. Wolfe JT 3rd and Stark ME. Alendronate-associated esophagitis: endoscopic and pathologic features. Gastrointest Endosc 1998;47:525-528.
10. Peter CP, Handt LK and Smith SM. Esophageal irritation due to alendronate sodium tablets: possible mechanisms. Dig Dis Sci 1998;43: 1998-2002.